Top Tech Companies (2,068)
Don't see your company?
Create a company profile
Invicro was founded with a mission of improving the role and function of imaging in translational drug discovery and development. To this effort we offer a suite of services and software with applications ranging from tissue to human, from target identification to Phase IV trials across the entire electromagnetic spectrum of imaging techniques. We start all projects with a data-driven mentality and the knowledge that quality data are the key to solving scientific challenges. Our analytics team is constantly innovating to develop the processes by which true and valuable quantitative information is extracted. Our approach has always been one of a scientific partner and collaborator, offering the service of our 200+ researchers on our team from a broad array of disciplines.
Cordata Healthcare Innovations offers specialized software applications for effective patient management.
Cardiovascular EMR Software Company
Elex Biotech Inc is a drug discovery and development company focused on first-in-class new chemical entities (NCEs) for the treatment of arrhythmia and heart failure. Using rational drug design and an internally generated SAR database, the Company has generated ~200 NCEs that stabilize mutant or dysfunctional Ryanodine receptor type 2 (RyR2), the Ca release channel that regulates the strength and frequency of heart muscle contractions. Certain arrhythmias and heart failure share a common defect in Ca handling resulting from RyR2 dysfunction that is addressed by Elex Biotech’s compounds. Elex Biotech has demonstrated in vivo proof of concept in animal models of catecholaminergic polymorphic ventricular tachycardia (CPVT), an orphan disease estimated to cause 15% of unexplained sudden cardiac death in apparently healthy young people.
Dianthus is a biotechnology company dedicated to designing and delivering the next generation of best-in-class monoclonal antibodies with improved selectivity and potency. Led by a multidisciplinary team of seasoned biotech entrepreneurs and scientists, we are pioneering selective antibodies of validated and emerging complement targets to allow people with rare and severe autoimmune diseases live healthier lives to their fullest potential.
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain. DiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.
Cmxtwenty focuses on developing lipid compounds for use in non-narcotic pain treatment.
At VRL, our priority is to ensure our clients accessibility to the highest level of expertise and customer service in the industry. We are dedicated to providing you non-biased high-quality results with fast turnaround time and unmatched customer service. Our scientific knowledge is well documented with multiple scientific publications in peer-reviewed journals. Our continued growth is an indication of our commitment to bring you the best all-around service possible.
We believe it is time to bring a fresh approach to treating common illnesses. We are Vesalius Therapeutics.
Genesee Scientific, a life science products company, is a leading supplier of products to global life science research markets. With thousands of products available, its markets include pharmaceutical and biotechnology companies, medical research institutions, research and development laboratories, universities, colleges and secondary education institutions, hospitals, reference labs, and quality control/process control laboratories.
Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine. Our highly sensitive and cost-effective mass spectrometry-based platform, the MassARRAY® System, is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics and clinical research. Our mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionable mutations, or enabling routine genetic testing for tens to thousands of samples, our products and services help laboratories translate genomic discoveries into mainstream clinical practice. Headquartered in San Diego, with offices located around the world, Agena Bioscience fosters a highly collaborative culture for both our customers and employees, encouraging diversity, creativity, and most importantly, innovation.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 50 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit www.sciex.com.
Sinapis Pharma is a clinical stage biotechnology company that has identified a new use and route of administration for methamphetamine.
Mindera Health™ is commercializing scalable extraction technology and data analysis to report a patient’s individual transcriptomic data. Mindera’s technology creates Dermal Intelligence™, actionable information for payers, providers and patients. The company’s flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patient’s receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity.
HelixNano is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology
Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next generation immunotherapeutics.
Parachute is a new kind of plasma donation company that allows individuals to earn money while creating life-saving medicine. Plasma is used to create medicine that treats chronic illnesses, including immune disorders, liver disease, bleeding disorders, and cancer. Right now, there’s a severe plasma shortage, which is impacting patients’ access to these life-saving treatments
Volumetric is an advanced biomaterials and biofabrication company.
